[1]
|
A Trinity Nano-Vaccine System with Spatiotemporal Immune Effect for the Adjuvant Cancer Therapy after Radiofrequency Ablation
ACS Nano,
2024
DOI:10.1021/acsnano.3c03352
|
|
|
[2]
|
Polymer–Protein Nanovaccine Synthesized via Reactive Self‐Assembly with Potential Application in Cancer Immunotherapy: Physicochemical and Biological Characterization In Vitro and In Vivo
Macromolecular Rapid Communications,
2023
DOI:10.1002/marc.202300438
|
|
|
[3]
|
Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis
European Archives of Oto-Rhino-Laryngology,
2023
DOI:10.1007/s00405-023-07884-3
|
|
|
[4]
|
Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis
European Archives of Oto-Rhino-Laryngology,
2023
DOI:10.1007/s00405-023-07884-3
|
|
|
[5]
|
OpenPBTA: The Open Pediatric Brain Tumor Atlas
Cell Genomics,
2023
DOI:10.1016/j.xgen.2023.100340
|
|
|
[6]
|
Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4+/CD8+ tumor infiltrating lymphocytes (TILs) ratio
Journal of Immunoassay and Immunochemistry,
2022
DOI:10.1080/15321819.2021.1981377
|
|
|
[7]
|
Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy
Biomaterials,
2022
DOI:10.1016/j.biomaterials.2022.121411
|
|
|
[8]
|
Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor immunotherapy
Materials Today Bio,
2022
DOI:10.1016/j.mtbio.2022.100497
|
|
|
[9]
|
Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy
Biomaterials,
2022
DOI:10.1016/j.biomaterials.2022.121411
|
|
|
[10]
|
A first‐in‐class, first‐in‐human, phase I trial of
CIGB
‐552, a synthetic peptide targeting
COMMD1
to inhibit the oncogenic activity of
NF‐κB
in patients with advanced solid tumors
International Journal of Cancer,
2021
DOI:10.1002/ijc.33695
|
|
|
[11]
|
Cytotoxic T cells response with decreased CD4/CD8 ratio during mammary tumors inhibition in rats induced by non-contact electric fields
F1000Research,
2021
DOI:10.12688/f1000research.27952.2
|
|
|
[12]
|
Cytotoxic T cells response with decreased CD4/CD8 ratio during mammary tumors inhibition in rats induced by non-contact electric fields
F1000Research,
2021
DOI:10.12688/f1000research.27952.1
|
|
|
[13]
|
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
Journal of Clinical Medicine,
2021
DOI:10.3390/jcm10163709
|
|
|
[14]
|
The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study
Applied Immunohistochemistry & Molecular Morphology,
2021
DOI:10.1097/PAI.0000000000000865
|
|
|
[15]
|
A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens
Asian Journal of Pharmaceutical Sciences,
2020
DOI:10.1016/j.ajps.2020.06.006
|
|
|
[16]
|
Oncolytic virotherapy: Challenges and solutions
Current Problems in Cancer,
2020
DOI:10.1016/j.currproblcancer.2020.100639
|
|
|
[17]
|
The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma
Applied Immunohistochemistry & Molecular Morphology,
2020
DOI:10.1097/PAI.0000000000000865
|
|
|
[18]
|
Synthesis of Poly(acyclic orthoester)s: Acid‐Sensitive Biomaterials for Enhancing Immune Responses of Protein Vaccine
Angewandte Chemie International Edition,
2020
DOI:10.1002/anie.202001169
|
|
|
[19]
|
Synthesis of Poly(acyclic orthoester)s: Acid‐Sensitive Biomaterials for Enhancing Immune Responses of Protein Vaccine
Angewandte Chemie,
2020
DOI:10.1002/ange.202001169
|
|
|
[20]
|
“Minimalist” Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy
ACS Nano,
2018
DOI:10.1021/acsnano.8b00558
|
|
|
[21]
|
Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters
Gene Therapy,
2018
DOI:10.1038/s41434-018-0006-y
|
|
|
[22]
|
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
Cancer Immunology, Immunotherapy,
2018
DOI:10.1007/s00262-018-2221-1
|
|
|
[23]
|
“Minimalist” Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy
ACS Nano,
2018
DOI:10.1021/acsnano.8b00558
|
|
|
[24]
|
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
Cancer Immunology, Immunotherapy,
2017
DOI:10.1007/s00262-016-1949-8
|
|
|
[25]
|
A complementary method to CD4 counting: measurement of CD4+/CD8+ T lymphocyte ratio in a tandem affinity microfluidic system
Biomedical Microdevices,
2015
DOI:10.1007/s10544-015-0023-1
|
|
|